TLR4 and neoplasm: If inflammation facilitates tumor progression through the induction of more suppressive MDSCby signaling through the toll-like receptor 4 (TLR4) pathway, then it is possible that a decreased pro-inflammatory microenvironment may reduce the potency of MDSC.